Detecting signals in pharmacogenomic genome-wide association studies
{{output}}
In a common pharmacogenomic scenario, outcome measures are compared for treated and untreated subjects across genotype-defined subgroups. The key question is whether treatment benefit (or harm) is particularly strong in certain subgroups, and therefore the sta... ...
